Search





Search





Markets
/
Stocks
/
nrix
/

Nurix Therapeutics Inc

NRIX

Add to Watchlist

23.210USD

-0.370-1.57%

Close 07-31 16:00（ET）Quotes delayed by 15 min

2.41BMarket Cap

LossP/E TTM

Nurix Therapeutics Inc

23.210

-0.370-1.57%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

NRIX Cash Flow Statement

You can access the annual and quarterly cash flow statements of Nurix Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-52.90%-96.57M

-17.72%-71.91M

-39.14%-67.83M

-36.06%-57.38M

-59.08%-63.16M

-45.62%-61.09M

-282.66%-48.75M

-2.54%-42.18M

-114.98%-39.70M

13.42%-41.95M

170.32%26.69M

11.18%-41.13M

43.89%-18.47M

-13.66%-48.45M

-22.79%-37.95M

-54.50%-46.31M

-4.37%-32.91M

-629.37%-42.63M

-50.92%-30.91M

-388.06%-29.97M

-118.55%-31.54M

-80.35%8.05M

-60.67%-20.48M

-116.88%-6.14M

-8.16%-14.43M

523.18%40.97M

---12.75M

--36.37M

---13.34M

---9.68M

Net income from continuing operations

-106.00%-89.53M

-54.70%-87.17M

-33.60%-78.22M

-76.53%-86.42M

2.43%-43.46M

-35.73%-56.35M

-39.55%-58.55M

-32.38%-48.96M

-83.49%-44.55M

-1.93%-41.52M

10.19%-41.96M

19.09%-36.98M

46.53%-24.28M

4.23%-40.73M

-23.91%-46.72M

-58.52%-45.71M

-72.09%-45.40M

-75.21%-42.53M

-89.32%-37.70M

-55.72%-28.84M

-448.05%-26.38M

-95.91%-24.27M

-47.30%-19.91M

-662.96%-18.52M

347.07%7.58M

-361.49%-12.39M

---13.52M

---2.43M

---3.07M

---2.69M

Operating gains losses

-55.76%2.25M

-46.80%2.20M

-50.73%2.12M

-51.09%2.03M

24.59%5.10M

6.17%4.13M

14.53%4.30M

22.52%4.15M

22.74%4.09M

22.26%3.89M

23.71%3.76M

17.26%3.38M

26.63%3.33M

41.15%3.18M

-24.99%3.04M

287.38%2.89M

308.06%2.63M

250.39%2.25M

528.73%4.05M

35.45%745.00K

30.30%645.00K

30.96%643.00K

17.30%644.00K

-1.08%550.00K

-17.91%495.00K

-23.99%491.00K

--549.00K

--556.00K

--603.00K

--646.00K

Other non-cash items

101.41%38.00K

88.81%-398.00K

118.44%644.00K

122.66%775.00K

-25.10%-2.70M

-84.30%-3.56M

-77.49%-3.49M

-107.90%-3.42M

-118.08%-2.16M

-135.94%-1.93M

-202.77%-1.97M

-2081.93%-1.65M

-251.84%-990.00K

-250.92%-818.00K

-207.26%-650.00K

-84.46%83.00K

89.53%652.00K

144.14%542.00K

323.78%606.00K

567.50%534.00K

719.05%344.00K

2675.00%222.00K

--143.00K

2766.67%80.00K

189.36%42.00K

113.56%8.00K

--0.00

---3.00K

---47.00K

---59.00K

Change in working capital

36.21%-20.72M

127.79%3.90M

-445.21%-1.55M

709.44%16.46M

-447.14%-32.48M

-37.36%-14.03M

-99.24%449.00K

81.73%-2.70M

-12.04%-5.94M

45.14%-10.21M

3160.35%58.82M

-40.04%-14.78M

-319.02%-5.30M

-107.72%-18.62M

29.00%-1.92M

-53.94%-10.56M

123.98%2.42M

-131.16%-8.96M

30.43%-2.71M

-164.50%-6.86M

56.19%-10.09M

-45.41%28.76M

-7174.55%-3.89M

-72.10%10.63M

-110.54%-23.02M

785.51%52.69M

--55.00K

--38.11M

---10.93M

---7.69M

-Change in receivables

----

--19.00M

---19.00M

----

-100.00%0.00

----

--2.00M

---2.00M

----

100.00%0.00

-100.00%0.00

571.14%8.00M

-127.16%-2.00M

86.65%-1.00M

-96.98%475.00K

91.33%-1.70M

--7.37M

---7.49M

--15.73M

---19.59M

----

--0.00

----

-Change in prepaid expenses

-92.01%263.00K

120.59%1.29M

-4.73%-1.28M

-247.89%-1.98M

1846.75%3.29M

-635.27%-6.25M

-194.00%-1.23M

-127.93%-570.00K

-92.11%169.00K

171.79%1.17M

-136.07%-417.00K

377.69%2.04M

214300.00%2.14M

-7.46%-1.63M

93.31%1.16M

85.87%-735.00K

99.95%-1.00K

-213.41%-1.51M

32.01%598.00K

-122.54%-5.20M

-234.07%-2.17M

136.32%1.33M

69.03%453.00K

-4350.91%-2.34M

5300.00%1.62M

-898.91%-3.68M

--268.00K

--55.00K

--30.00K

---368.00K

-Change in other current liabilities

-23.95%-7.04M

87.26%-1.25M

-2.21%-13.58M

-4.03%-7.89M

-215.77%-5.68M

21.93%-9.83M

-126.13%-13.28M

53.92%-7.59M

186.47%4.91M

-37.04%-12.59M

1287.02%50.84M

-77.21%-16.47M

50.34%-5.68M

-466.91%-9.18M

-206.59%-4.28M

-118.53%-9.29M

-149.01%-11.43M

-109.54%-1.62M

-272.26%-1.40M

-4.06%-4.25M

-44.33%-4.59M

-68.90%16.99M

143.56%811.00K

-110.92%-4.09M

66.30%-3.18M

691.67%54.63M

---1.86M

--37.42M

---9.44M

---9.23M

Cash from non-recurring investing activities

Cash from operating activities

-52.90%-96.57M

-17.72%-71.91M

-39.14%-67.83M

-36.06%-57.38M

-59.08%-63.16M

-45.62%-61.09M

-282.66%-48.75M

-2.54%-42.18M

-114.98%-39.70M

13.42%-41.95M

170.32%26.69M

11.18%-41.13M

43.89%-18.47M

-13.66%-48.45M

-22.79%-37.95M

-54.50%-46.31M

-4.37%-32.91M

-629.37%-42.63M

-50.92%-30.91M

-388.06%-29.97M

-118.55%-31.54M

-80.35%8.05M

-60.67%-20.48M

-116.88%-6.14M

-8.16%-14.43M

523.18%40.97M

---12.75M

--36.37M

---13.34M

---9.68M

Investing cash flow

Net cash from continuing investing activities

-27.63%1.94M

-70.01%1.04M

143.75%5.13M

15.51%2.71M

38.10%2.67M

20.84%3.48M

-18.57%2.10M

-4.55%2.35M

79.35%1.94M

26.66%2.88M

0.78%2.58M

-28.06%2.46M

-61.28%1.08M

-34.42%2.28M

197.56%2.56M

83.27%3.42M

33.38%2.79M

311.86%3.47M

-4.86%862.00K

11.68%1.86M

29.63%2.09M

131.59%843.00K

-4.93%906.00K

238.74%1.67M

3484.44%1.61M

127.50%364.00K

--953.00K

--493.00K

--45.00K

--160.00K

Capital expenditures

-27.63%1.94M

-70.01%1.04M

143.75%5.13M

15.51%2.71M

38.10%2.67M

20.84%3.48M

-18.57%2.10M

-4.55%2.35M

79.35%1.94M

26.66%2.88M

0.78%2.58M

-28.06%2.46M

-61.28%1.08M

-34.42%2.28M

197.56%2.56M

83.27%3.42M

33.38%2.79M

311.86%3.47M

-4.86%862.00K

11.68%1.86M

29.63%2.09M

131.59%843.00K

-4.93%906.00K

238.74%1.67M

3484.44%1.61M

127.50%364.00K

--953.00K

--493.00K

--45.00K

--160.00K

Net cash flow from disposal of fixed assets

-27.63%1.94M

-70.01%1.04M

143.75%5.13M

15.51%2.71M

38.10%2.67M

20.84%3.48M

-18.57%2.10M

-4.55%2.35M

79.35%1.94M

26.66%2.88M

0.78%2.58M

-28.06%2.46M

-61.28%1.08M

-34.42%2.28M

197.56%2.56M

83.27%3.42M

33.38%2.79M

311.86%3.47M

-4.86%862.00K

11.68%1.86M

29.63%2.09M

131.59%843.00K

-4.93%906.00K

238.74%1.67M

3484.44%1.61M

127.50%364.00K

--953.00K

--493.00K

--45.00K

--160.00K

Net cash flow from investment products

27.99%94.93M

-523.12%-122.78M

103.95%5.48M

380.04%53.19M

157.44%74.17M

-24.43%29.02M

-1076.72%-138.71M

-175.26%-18.99M

-387.53%-129.13M

109.30%38.40M

-120.47%-11.79M

142.30%25.23M

2372.82%44.91M

-57.83%18.34M

261.45%57.57M

-475.52%-59.66M

96.41%-1.98M

2917.55%43.50M

71.16%-35.66M

90.26%-10.37M

-7509.82%-55.02M

91.90%-1.54M

-3524.18%-123.66M

-2760.28%-106.41M

-107.23%-723.00K

-4241.69%-19.06M

---3.41M

--4.00M

--10.00M

---439.00K

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

30.07%93.00M

-584.96%-123.83M

100.25%346.00K

336.54%50.48M

154.55%71.50M

-28.10%25.53M

-879.73%-140.82M

-193.69%-21.34M

-399.03%-131.07M

121.02%35.51M

-126.13%-14.37M

136.11%22.77M

1019.85%43.83M

-59.86%16.07M

250.61%55.01M

-415.71%-63.08M

91.66%-4.76M

1777.04%40.03M

70.68%-36.52M

88.68%-12.23M

-2344.78%-57.11M

87.71%-2.39M

-2753.68%-124.56M

-3181.86%-108.08M

-123.47%-2.34M

-3142.74%-19.42M

---4.37M

--3.51M

--9.96M

---599.00K

Financing cash flow

Cash flow from continuous financing activities

1000.00%66.00K

1256.08%19.98M

17.70%236.01M

-97.48%1.16M

-100.00%6.00K

-9.30%1.47M

2864485.71%200.52M

2586.03%45.77M

950908.00%237.75M

9.66%1.62M

105.19%7.00K

-98.52%1.70M

-94.21%25.00K

-0.47%1.48M

-127.00%-135.00K

7336.02%115.41M

-99.71%432.00K

9.49%1.49M

144.40%500.00K

-99.30%1.55M

25.72%150.47M

2854.35%1.36M

-1507.50%-1.13M

3148957.14%220.42M

260082.61%119.68M

557.14%46.00K

--80.00K

---7.00K

--46.00K

--7.00K

Net cash flow from common stock issuance/repurchase

--0.00

1465.50%19.60M

17.93%234.76M

-97.71%977.00K

-100.00%0.00

-1.34%1.25M

--199.07M

5407.09%42.73M

--237.55M

-12.66%1.27M

--0.00

-96.18%776.00K

--0.00

36.56%1.45M

--0.00

1895.18%20.29M

-100.00%0.00

2.01%1.06M

100.00%0.00

-99.54%1.02M

--150.16M

--1.04M

---1.15M

--219.30M

----

--0.00

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

--0.00

--119.91M

----

--0.00

----

Proceeds from stock option exercised by employees

1000.00%66.00K

69.68%375.00K

-14.01%1.25M

-94.14%178.00K

-97.01%6.00K

-37.75%221.00K

20600.00%1.45M

227.05%3.04M

704.00%201.00K

1167.86%355.00K

-85.42%7.00K

433.33%928.00K

-94.21%25.00K

-93.40%28.00K

-90.40%48.00K

-67.48%174.00K

37.58%432.00K

34.18%424.00K

1685.71%500.00K

-29.51%535.00K

141.54%314.00K

586.96%316.00K

-65.00%28.00K

10942.86%759.00K

182.61%130.00K

557.14%46.00K

--80.00K

---7.00K

--46.00K

--7.00K

Proceeds from issuance of warrants

----

100.00%0.00

----

---183.00K

--94.94M

----

Net cash flow from other financing activities

--0.00

----

--360.00K

---360.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

1000.00%66.00K

1256.08%19.98M

17.70%236.01M

-97.48%1.16M

-100.00%6.00K

-9.30%1.47M

2864485.71%200.52M

2586.03%45.77M

950908.00%237.75M

9.66%1.62M

105.19%7.00K

-98.52%1.70M

-94.21%25.00K

-0.47%1.48M

-127.00%-135.00K

7336.02%115.41M

-99.71%432.00K

9.49%1.49M

144.40%500.00K

-99.30%1.55M

25.72%150.47M

2854.35%1.36M

-1507.50%-1.13M

3148957.14%220.42M

260082.61%119.68M

557.14%46.00K

--80.00K

---7.00K

--46.00K

--7.00K

Net cash flow

Beginning cash balance

-6.06%72.16M

123.56%247.93M

-20.55%79.41M

-27.64%85.16M

51.47%76.82M

99.72%110.90M

131.33%99.94M

96.61%117.69M

47.12%50.71M

-15.06%55.53M

-10.84%43.20M

41.06%59.86M

-56.74%34.47M

-19.08%65.38M

-67.20%48.46M

-77.47%42.43M

-37.04%79.68M

-32.41%80.79M

-44.40%147.73M

18.11%188.38M

123.67%126.55M

241.64%119.53M

410.77%265.70M

1213.07%159.50M

265.34%56.58M

35.81%34.99M

--52.02M

--12.15M

--15.49M

--25.76M

Current period cash flow changes

-142.07%-3.51M

-415.73%-175.76M

1438.59%168.52M

67.57%-5.75M

-87.54%8.34M

-607.96%-34.08M

-11.12%10.95M

-6.56%-17.75M

163.82%66.98M

84.42%-4.81M

-27.16%12.32M

-376.51%-16.65M

168.16%25.39M

-2681.55%-30.90M

125.28%16.92M

114.82%6.02M

-160.24%-37.25M

-115.81%-1.11M

54.21%-66.93M

-138.28%-40.65M

-39.93%61.83M

-67.47%7.03M

-758.16%-146.17M

166.35%106.20M

3181.41%102.92M

310.18%21.59M

---17.03M

--39.87M

---3.34M

---10.27M

Ending cash balance

-19.38%68.65M

-6.06%72.16M

123.56%247.93M

-20.55%79.41M

-27.64%85.16M

51.47%76.82M

99.72%110.90M

131.33%99.94M

96.61%117.69M

47.12%50.71M

-15.06%55.53M

-10.84%43.20M

41.06%59.86M

-56.74%34.47M

-19.08%65.38M

-67.20%48.46M

-77.47%42.43M

-37.04%79.68M

-32.41%80.79M

-44.40%147.73M

18.11%188.38M

123.67%126.55M

241.64%119.53M

410.77%265.70M

1213.07%159.50M

265.34%56.58M

--34.99M

--52.02M

--12.15M

--15.49M

Free cash flow

-49.63%-98.51M

-12.99%-72.96M

-43.47%-72.96M

-34.97%-60.10M

-58.10%-65.84M

-44.02%-64.57M

-310.99%-50.86M

-2.14%-44.52M

-113.01%-41.64M

11.62%-44.84M

159.49%24.10M

12.34%-43.59M

45.25%-19.55M

-10.04%-50.73M

-27.53%-40.52M

-56.19%-49.73M

-6.18%-35.70M

-739.42%-46.10M

-48.56%-31.77M

-307.59%-31.84M

-109.61%-33.63M

-82.24%7.21M

-56.11%-21.39M

-121.77%-7.81M

-19.84%-16.04M

512.60%40.61M

---13.70M

--35.88M

---13.39M

---9.84M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Nurix Therapeutics Inc Generate?



Nurix Therapeutics Inc generated -249.47M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Nurix Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Nurix Therapeutics Inc's operating cash flow increased by -44.55% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Nurix Therapeutics Inc Spend on Capital Expenditures?



Nurix Therapeutics Inc spent 14.00M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Nurix Therapeutics Inc's Financing Cash Flow Changed?



Nurix Therapeutics Inc used 238.64M in financing activities in the latest quarter.

What is free cash flow and why does it matter for NRIX?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Nurix Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -263.47M reflecting a -44.88% change from the previous year.